{"id":5662,"date":"2017-02-23T20:52:57","date_gmt":"2017-02-24T01:52:57","guid":{"rendered":"http:\/\/localhost:10028\/practiceareas\/pradaxa\/"},"modified":"2022-06-21T16:54:03","modified_gmt":"2022-06-21T20:54:03","slug":"pradaxa","status":"publish","type":"practiceareas","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/uygulama-alanlari-2\/pradaxa\/","title":{"rendered":"Pradaxa"},"content":{"rendered":"<h2 class=\"update-highlight\" style=\"text-align: center; background-color: red;\">ARTIK PRADAXA VAKALARINI KABUL ETM\u0130YORUZ<\/h2>\n<p>Atriyal fibrilasyon t\u0131bbi durumundan muzdarip ki\u015filer, felce yol a\u00e7an bir kan p\u0131ht\u0131s\u0131 geli\u015ftirme riski alt\u0131nda olabilir. Pradaxa (dabigatran), kan p\u0131ht\u0131la\u015fmas\u0131 ve inme riskiyle m\u00fccadele etmek i\u00e7in kandaki trombositlerin p\u0131ht\u0131la\u015fmas\u0131n\u0131 \u00f6nler. Ne yaz\u0131k ki kan suland\u0131r\u0131c\u0131n\u0131n da ciddi yan etkileri var.<\/p>\n<p>&nbsp;<\/p>\n<h3>Pradaxa&#039;n\u0131n Bir\u00e7ok Tehlikeli Yan Etkisi<\/h3>\n<p>Pradaxa&#039;n\u0131n, baz\u0131lar\u0131 \u00f6l\u00fcmc\u00fcl olabilen bir\u00e7ok tehlikeli yan etkisi vard\u0131r. Bunlar a\u015fa\u011f\u0131daki riskleri i\u00e7erir:<\/p>\n<ul>\n<li>Kontrols\u00fcz ve \u015fiddetli kanama;<\/li>\n<li>Beyin kanamalar\u0131;<\/li>\n<li>Karaci\u011fer yetmezli\u011fi;<\/li>\n<li>Spinal kan p\u0131ht\u0131lar\u0131; Ve<\/li>\n<li>Kalp krizi.<\/li>\n<\/ul>\n<p>Pradaxa, s\u00f6zde g\u00fcvenli\u011fi nedeniyle ba\u015fka bir antikoag\u00fclan ila\u00e7 olan Warfarin&#039;e alternatif olarak piyasaya s\u00fcr\u00fcl\u00fcrken, <em>HAYIR<\/em> Bir hasta Pradaxa al\u0131rken kontrol edilemeyen kanama ge\u00e7irirse panzehir (orada <em>d\u0131r-dir<\/em> Warfarin&#039;in neden oldu\u011fu kanamaya kar\u015f\u0131 bir panzehir). <a href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM231720.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">FDA&#039;ya g\u00f6re<\/a>75 ya\u015f \u00fcst\u00fc, b\u00f6brek problemi olan, mide \u00fclseri olan veya kan suland\u0131r\u0131c\u0131 ba\u015fka ila\u00e7lar kullanan hastalarda kanama riski artar.<\/p>\n<p>&nbsp;<\/p>\n<h3>Pradaxa Davas\u0131 A\u00e7mak<\/h3>\n<p>When a defective drug causes a patient harm, the patient (or the patient\u2019s family) has the right to take legal action directly against the drug\u2019s manufacturer. The manufacturer of Pradaxa is Boehringer Ingelheim, which has already settled a handful of Pradaxa lawsuits and claims. If you believe that you may be eligible to receive a settlement award based on harm that you have suffered as a direct result of taking Pradaxa, you need to consult with an attorney who is experienced in <a class=\"wpil_keyword_link\" href=\"https:\/\/napolilaw.lemonadestand.org\/tr\/uygulama-alanlari-2\/ilac-davasi\/\" title=\"ila\u00e7 davas\u0131\" data-wpil-keyword-link=\"linked\" data-wpil-monitor-id=\"68\">ila\u00e7 davas\u0131<\/a> hemen.<\/p>\n<p>&nbsp;<\/p>\n<h3>Yak\u0131n\u0131n\u0131zdaki Bir Kusurlu \u0130la\u00e7 Avukat\u0131yla Bug\u00fcn \u0130leti\u015fime Ge\u00e7in<\/h3>\n<p>Napoli Shkolnik, PLLC&#039;de yetenekli ay\u0131pl\u0131 ila\u00e7 avukatlar\u0131m\u0131z\u0131n ABD genelinde bir\u00e7ok eyalette ofisi vard\u0131r ve \u00fclke \u00e7ap\u0131nda kusurlu ila\u00e7 ma\u011fdurlar\u0131na hizmet vermektedir. Y\u0131llar\u0131n verdi\u011fi deneyimle, kusurlu bir farmas\u00f6tik talebini kazanmak i\u00e7in ne gerekti\u011fini biliyoruz. Hak kazand\u0131\u011f\u0131n\u0131z zararlar\u0131 tazmin etmenize nas\u0131l yard\u0131mc\u0131 olabilece\u011fimiz hakk\u0131nda daha fazla bilgi edinmek i\u00e7in bug\u00fcn bizi aray\u0131n ve bir dan\u0131\u015fma randevusu ayarlay\u0131n.<\/p>","protected":false},"excerpt":{"rendered":"<p>ARTIK PRADAXA VAKALARINI KABUL ETM\u0130YORUZ Atriyal fibrilasyon t\u0131bbi durumundan mustarip ki\u015filer, felce yol a\u00e7an bir kan p\u0131ht\u0131s\u0131 geli\u015ftirme riski alt\u0131nda olabilir. M\u00fccadele etmek\u2026<\/p>","protected":false},"featured_media":0,"menu_order":185,"template":"","practiceareas_category":[743],"class_list":["post-5662","practiceareas","type-practiceareas","status-publish","hentry","practiceareas_category-pharmaceutical-litigation"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/practiceareas"}],"version-history":[{"count":1,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5662\/revisions"}],"predecessor-version":[{"id":18250,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas\/5662\/revisions\/18250"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=5662"}],"wp:term":[{"taxonomy":"practiceareas_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/practiceareas_category?post=5662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}